Physician profile
Danielle Velez Leitner
NPI 1245618891
$5,013.71
in general payments reported to CMS, 2019-2025
7 companies · $2,808 in 2025
The $2,808 reported for 2025 was more than what 86% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.78 · 2022: $1,495 · 2023: $176 · 2024: $514 · 2025: $2,808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,952 · Travel and Lodging: $1,096 · Consulting Fee: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,952.38 |
| Travel and Lodging | $1,095.79 |
| Consulting Fee | $450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,361.80 | 2021-2025 | General - Erectile Dysfunction, Ams 700, General - Therapies |
| Procept Biorobotics Corporation | $205.01 | 2025 | |
| Axonics, INC. | $149.12 | 2024 | Axonics, Bulkamid |
| Urogen Pharma, INC. | $113.96 | 2023 | Jelmyto |
| Valencia Technologies Corporation | $103.37 | 2025 | Ecoin Device Kit |
| Coloplast Corp | $48.88 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $31.57 | 2023 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Velez Leitner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.